Last updated 2026-08-21
Total raised
—
Stage
—
Founded
2020
Headcount
—
HQ
Tel Aviv, Israel
Sector
Healthtech
About
MedFlag, also known as Medial EarlySign, is an Israeli startup that has developed machine learning-based software to analyze standard blood test results and identify patients at high risk of colon cancer. The product, called ColonFlag, does not directly diagnose colon cancer but flags high-risk patients for further testing. The company has studied medical records of approximately 20 million individuals across Israel, the UK, the US, and Asia Pacific to train its algorithms.
Q&A
- What is MedFlag's primary focus?
- MedFlag develops machine learning-based software to analyze standard blood test results and identify patients at high risk of colon cancer.
- What is the name of MedFlag's main product?
- MedFlag's product is called ColonFlag.
- What is the function of ColonFlag?
- ColonFlag flags high-risk patients for further testing, rather than directly diagnosing colon cancer.
- What technologies does MedFlag utilize?
- MedFlag utilizes Machine Learning and Artificial Intelligence in its core technology.
- What markets has MedFlag studied to train its algorithms?
- MedFlag has studied medical records of approximately 20 million individuals across Israel, the UK, the US, and Asia Pacific to train its algorithms.
- Where is MedFlag headquartered?
- MedFlag is headquartered in Tel Aviv, Israel.
- What sector does MedFlag operate in?
- MedFlag operates in the Healthtech sector, with sub-sectors including Medical Diagnostics, Machine Learning, and Oncology.
Sectors & technology
Primary sector
Healthtech
Technologies
Target customers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2020 |
|---|